2BBBullish & Bearish
Ionis Pharmaceuticals, Inc. (IONS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 61 out of 100.
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.
Ionis Pharmaceuticals, Inc.’s current 2BB score is 61 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 76 | High |
| Momentum | 57 | Stable |
| Financial strength | 13 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 45 | Moderate |
| CEO | Brett P. Monia Ph.D. |
| Headquarters | Carlsbad, California, United States |
| Founded | 1989 |
| Employees | 1.48K |
| 52-week range | $42.19 – $86.74 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-23 | — | -1.0711 | — | $234.89M |
| 2026-10-27 | — | -1.2315 | — | $186.04M |
| 2026-07-29 | — | -1.115 | — | $192.59M |
| 2026-04-29 | -0.56 | -0.9283 | $246.09M | $199.54M |